Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ide Smets

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Multiple Sclerosis and Related Disorders|December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational studyIde Smets, David Holden, Lucia Bianchi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 28, 2016
Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterationsJames Dooley, Ine Pauwels, Dean Franckaert, et al.
Brain : a Journal of Neurology|January 24, 2018
Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cellsIde Smets, Barnaby Fiddes, Josselyn E Garcia-Perez, et al.
Cell Reports|October 18, 2018
Genetic Architecture of Adaptive Immune System Identifies Key Immune RegulatorsVasiliki Lagou, Josselyn E Garcia-Perez, Ide Smets, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2026
Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple SclerosisKirsten L Kuiper, Laurens Bogers, Jasper Rip, et al.
Annals of Clinical and Translational Neurology|February 21, 2025
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort studyRobin W van Steenhoven, Saan Salih, Juna M de Vries, et al.
European Journal of Immunology|September 3, 2025
Perturbances in Both Circulating B and CD4<sup>+</sup> T Cells Discriminate Multiple Sclerosis from Other Central Nervous System Autoimmune DiseasesLaurens Bogers, Jasper Rip, Suzanne C Franken, et al.
Ebiomedicine|June 6, 2026
Refined single-cell profiling captures a CCR5<sup>high</sup> CD4<sup>+</sup> cytotoxic T-cell precursor in multiple sclerosisFabiënne van Puijfelik, Jasper Rip, Yifan van Hasselt, et al.
European Journal of Neurology|July 7, 2026
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of OcrelizumabLaura Hogenboom, Lisa G Schoof, Liza M Y Gelissen, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Multiple Sclerosis and Related Disorders|December 6, 2021
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational studyIde Smets, David Holden, Lucia Bianchi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 28, 2016
Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterationsJames Dooley, Ine Pauwels, Dean Franckaert, et al.
Brain : a Journal of Neurology|January 24, 2018
Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cellsIde Smets, Barnaby Fiddes, Josselyn E Garcia-Perez, et al.
Cell Reports|October 18, 2018
Genetic Architecture of Adaptive Immune System Identifies Key Immune RegulatorsVasiliki Lagou, Josselyn E Garcia-Perez, Ide Smets, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 16, 2026
Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple SclerosisKirsten L Kuiper, Laurens Bogers, Jasper Rip, et al.
Annals of Clinical and Translational Neurology|February 21, 2025
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort studyRobin W van Steenhoven, Saan Salih, Juna M de Vries, et al.
European Journal of Immunology|September 3, 2025
Perturbances in Both Circulating B and CD4<sup>+</sup> T Cells Discriminate Multiple Sclerosis from Other Central Nervous System Autoimmune DiseasesLaurens Bogers, Jasper Rip, Suzanne C Franken, et al.
Ebiomedicine|June 6, 2026
Refined single-cell profiling captures a CCR5<sup>high</sup> CD4<sup>+</sup> cytotoxic T-cell precursor in multiple sclerosisFabiënne van Puijfelik, Jasper Rip, Yifan van Hasselt, et al.
European Journal of Neurology|July 7, 2026
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of OcrelizumabLaura Hogenboom, Lisa G Schoof, Liza M Y Gelissen, et al.
Pageof 3